UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: October 28, 2020 5:00 P.M.
Form: S-1
CIK: 0000849636
Company Name: RespireRx Pharmaceuticals Inc.
File Number: 333-249469